Circulating adipokines in healthy versus unhealthy overweight and obese subjects

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Alfadda, Assim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893846571     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/170434     Document Type: Article

References (36)

1. Hu F. B., Willett W. C., Li T., Stampfer M. J., Colditz G. A., Manson J. E., Adiposity as compared with physical activity in predicting mortality among women. The New England Journal of Medicine 2004 351 26 2694 2703 2-s2.0-10844262691 10.1056/NEJMoa042135 (Pubitemid 39665323)
2. Blüher M., The distinction of metabolically "healthy" from "unhealthy" obese individuals. Current Opinion in Lipidology 2010 21 1 38 43 2-s2.0-77649171169 10.1097/MOL.0b013e3283346ccc
3. Brochu M., Tchernof A., Dionne I. J., Sites C. K., Eltabbakh G. H., Sims E. A. H., Poehlman E. T., What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? The Journal of Clinical Endocrinology and Metabolism 2001 86 3 1020 1025 2-s2.0-0035052940 10.1210/jc.86.3.1020 (Pubitemid 32322976)
4. Calori G., Lattuada G., Piemonti L., Garancini M. P., Ragogna F., Villa M., Mannino S., Crosignani P., Bosi E., Luzi L., Ruotolo G., Perseghin G., Prevalence, metabolic features, and prognosis of metabolically healthy obese italian individuals: the cremona study. Diabetes Care 2011 34 1 210 215 2-s2.0-79951694160 10.2337/dc10-0665
5. Hamer M., Stamatakis E., Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. The Journal of Clinical Endocrinology and Metabolism 2012 97 7 2482 2488
6. Meigs J. B., Wilson P. W. F., Fox C. S., Vasan R. S., Nathan D. M., Sullivan L. M., D'Agostino R. B., Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. The Journal of Clinical Endocrinology and Metabolism 2006 91 8 2906 2912 2-s2.0-33747739430 10.1210/jc.2006-0594 (Pubitemid 44271734)
7. Song Y., Manson J. E., Meigs J. B., Ridker P. M., Buring J. E., Liu S., Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. American Journal of Cardiology 2007 100 11 1654 1658 2-s2.0-36248990194 10.1016/j.amjcard.2007.06. 073 (Pubitemid 350130235)
8. Ogorodnikova A. D., Kim M., McGinn A. P., Muntner P., Khan U., Wildman R. P., Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 2012 20 3 651 659 2-s2.0-84857685253 10.1038/oby.2011.243
9. Flint A. J., Hu F. B., Glynn R. J., Caspard H., Manson J. E., Willett W. C., Rimm E. B., Excess weight and the risk of incident coronary heart disease among men and women. Obesity 2010 18 2 377 383 2-s2.0-75749124333 10.1038/oby.2009.223
10. Hubert H. B., Feinleib M., McNamara P. M., Castelli W. P., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983 67 5 968 977 2-s2.0-0020533259 (Pubitemid 13080473)
11. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
12. Visser M., Bouter L. M., McQuillan G. M., Wener M. H., Harris T. B., Elevated C-reactive protein levels in overweight and obese adults. The Journal of the American Medical Association 1999 282 22 2131 2135 2-s2.0-0033537013 10.1001/jama.282.22.2131
13. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. The Journal of the American Medical Association 2001 286 3 327 334 2-s2.0-0035908632 (Pubitemid 32656163)
14. Onat A., Can G., Hergenç G., Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008 57 2 207 214 2-s2.0-38049024079 10.1016/j.metabol.2007.09.002
15. Koster A., Stenholm S., Alley D. E., Kim L. J., Simonsick E. M., Kanaya A. M., Visser M., Houston D. K., Nicklas B. J., Tylavsky F. A., Satterfield S., Goodpaster B. H., Ferrucci L., Harris T. B., Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity 2010 18 12 2354 2361 2-s2.0-78649955475 10.1038/oby.2010.86
16. Labruna G., Pasanisi F., Nardelli C., Caso R., Vitale D. F., Contaldo F., Sacchetti L., High leptin/adiponectin ratio and serum triglycerides are associated with an at-risk phenotype in young severely obese patients. Obesity 2011 19 7 1492 1496 2-s2.0-79959678086 10.1038/oby.2010.309
17. Phillips C. M., Tierney A. C., Perez-Martinez P., Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity 2013 21 1 E154 E161
18. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
19. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
20. Wildman R. P., Muntner P., Reynolds K., McGinn A. P., Rajpathak S., Wylie-Rosett J., Sowers M. R., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine 2008 168 15 1617 1624 2-s2.0-49449106657 10.1001/archinte.168.15.1617
21. Karelis A. D., Rabasa-Lhoret R., Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes and Metabolism 2008 34 2 183 184 2-s2.0-42249098249 10.1016/j.diabet.2007.11.004
22. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., Häring H.-U., Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008 168 15 1609 1616 2-s2.0-49449092403 10.1001/archinte.168. 15.1609
23. Aguilar-Salinas C. A., García E., Robles L., Riaño D., Ruiz-Gomez D. G., García-Ulloa A. C., Melgarejo M. A., Zamora M., Guillen-Pineda L. E., Mehta R., Canizales-Quinteros S., Luna M. T. T., Gómez-Pérez F. J., High adiponectin concentrations are associated with the metabolically healthy obese phenotype. The Journal of Clinical Endocrinology and Metabolism 2008 93 10 4075 4079 2-s2.0-53249149870 10.1210/jc.2007-2724
24. Phillips C. M., Metabolically healthy obesity: definitions, determinants and clinical implications. Reviews in Endocrine and Metabolic Disorders 2013 14 3 219 227
25. Rajala M. W., Scherer P. E., Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003 144 9 3765 3773 2-s2.0-0042330251 10.1210/en.2003-0580 (Pubitemid 37088727)
26. Alfadda A. A., Sallam R. M., Chishti M. A., Moustafa A. S., Fatma S., Alomaim W. S., Al-Naami M. Y., Bassas A. F., Chrousos G. P., Jo H., Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism. Molecules and Cells 2012 33 6 591 596 2-s2.0-84860125341 10.1007/s10059-012-0012-7
27. Alfadda A. A., Fatma S., Chishti M. A., Al-Naami M. Y., Elawad R., Mendoza C. D. O., Jo H., Lee Y. S., Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Molecules and Cells 2012 33 1 35 41 2-s2.0-82255189622 10.1007/s10059-012-2181-9
28. Doumatey A. P., Bentley A. R., Zhou J., Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in African Americans. Journal of Endocrinology and Metabolism 2012 2 2 51 65
29. Ziemke F., Mantzoros C. S., Adiponectin in insulin resistance: lessons from translational research. American Journal of Clinical Nutrition 2010 91 1 2-s2.0-74049157079 10.3945/ajcn.2009.28449C
30. Satoh N., Naruse M., Usui T., Tagami T., Suganami T., Yamada K., Kuzuya H., Shimatsu A., Ogawa Y., Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004 27 10 2488 2490 2-s2.0-4644287729 10.2337/diacare.27.10.2488 (Pubitemid 39281406)
31. Kotani K., Sakane N., Saiga K., Kurozawa Y., Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005 48 12 2684 2686 2-s2.0-28444488589 10.1007/s00125-005-0015-4 (Pubitemid 41738239)
32. Liao Y. C., Liang K. W., Lee W. J., Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. Biomarkers 2013 18 1 44 50
33. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D., Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 148 10 4687 4694 2-s2.0-34748817386 10.1210/en.2007-0175 (Pubitemid 47481514)
34. Lee Y. S., Choi J. W., Hwang I., Lee J. W., Lee J. H., Kim A. Y., Huh J. Y., Koh Y. J., Koh G. Y., Son H. J., Masuzaki H., Hotta K., Alfadda A. A., Kim J. B., Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. The Journal of Biological Chemistry 2010 285 29 22174 22185 2-s2.0-77954606303 10.1074/jbc.M109.085464
35. Rourke J. L., Dranse H. J., Sinal C. J., Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews 2013 14 3 245 262
36. Fournier T., Medjoubi-N N., Porquet D., Alpha-1-acid glycoprotein. Biochimica et Biophysica Acta 2000 1482 1-2 157 171 2-s2.0-0034684197 10.1016/S0167-4838(00)00153-9